Senores Pharmaceuticals Limited (BOM:544319)
India flag India · Delayed Price · Currency is INR
1,042.95
-5.85 (-0.56%)
At close: Jun 4, 2026

Senores Pharmaceuticals Statistics

Total Valuation

BOM:544319 has a market cap or net worth of INR 47.65 billion. The enterprise value is 49.79 billion.

Market Cap47.65B
Enterprise Value 49.79B

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date May 14, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 46.05M
Shares Outstanding n/a
Shares Change (YoY) +21.26%
Shares Change (QoQ) -8.56%
Owned by Insiders (%) 36.28%
Owned by Institutions (%) 12.45%
Float 19.45M

Valuation Ratios

The trailing PE ratio is 40.94 and the forward PE ratio is 32.29.

PE Ratio 40.94
Forward PE 32.29
PS Ratio 7.53
PB Ratio 4.94
P/TBV Ratio 8.69
P/FCF Ratio n/a
P/OCF Ratio 76.80
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.58, with an EV/FCF ratio of -24.56.

EV / Earnings 42.78
EV / Sales 7.87
EV / EBITDA 29.58
EV / EBIT 36.32
EV / FCF -24.56

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.35.

Current Ratio 1.92
Quick Ratio 1.14
Debt / Equity 0.35
Debt / EBITDA 2.03
Debt / FCF -1.69
Interest Coverage 5.48

Financial Efficiency

Return on equity (ROE) is 13.79% and return on invested capital (ROIC) is 10.39%.

Return on Equity (ROE) 13.79%
Return on Assets (ROA) 6.05%
Return on Invested Capital (ROIC) 10.39%
Return on Capital Employed (ROCE) 11.62%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count194
Asset Turnover 0.45
Inventory Turnover 3.45

Taxes

In the past 12 months, BOM:544319 has paid 375.70 million in taxes.

Income Tax 375.70M
Effective Tax Rate 23.47%

Stock Price Statistics

The stock price has increased by +102.42% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +102.42%
50-Day Moving Average 927.55
200-Day Moving Average 805.87
Relative Strength Index (RSI) 52.31
Average Volume (20 Days) 34,438

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544319 had revenue of INR 6.33 billion and earned 1.16 billion in profits. Earnings per share was 26.39.

Revenue6.33B
Gross Profit 3.81B
Operating Income 1.37B
Pretax Income 1.60B
Net Income 1.16B
EBITDA 1.68B
EBIT 1.37B
Earnings Per Share (EPS) 26.39
Full Income Statement

Balance Sheet

The company has 1.60 billion in cash and 3.42 billion in debt, with a net cash position of -1.82 billion.

Cash & Cash Equivalents 1.60B
Total Debt 3.42B
Net Cash -1.82B
Net Cash Per Share n/a
Equity (Book Value) 9.65B
Book Value Per Share 235.10
Working Capital 3.88B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 620.50 million and capital expenditures -2.65 billion, giving a free cash flow of -2.03 billion.

Operating Cash Flow 620.50M
Capital Expenditures -2.65B
Depreciation & Amortization 312.50M
Net Borrowing 20.00M
Free Cash Flow -2.03B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 60.22%, with operating and profit margins of 21.67% and 18.40%.

Gross Margin 60.22%
Operating Margin 21.67%
Pretax Margin 25.31%
Profit Margin 18.40%
EBITDA Margin 26.61%
EBIT Margin 21.67%
FCF Margin n/a

Dividends & Yields

BOM:544319 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.26%
Shareholder Yield -21.26%
Earnings Yield 2.44%
FCF Yield -4.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:544319 is 1,174.25, which is 12.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target 1,174.25
Price Target Difference 12.59%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) 28.84%
EPS Growth Forecast (3Y) 29.26%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5